Digital Relevance and impact: Connecting with HCPs in the digital ag... What’s the best way to influence physician behaviour? This is the pharmaceutical industry’s billion-dollar question.
Patients Could virtual wards be the answer to NHS waiting lists? Hospitals across the UK are under pressure from increasing numbers of admissions year on year and an estimated 7.2 million people – one in eight of England’s population – are on a waiting l
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
